Genetic mutation associated with increased risk of lung cancer

	Tweet

Carriers of a common genetic disorder previously linked to lung disease may have a 70-percent to 100-percent increased risk of lung cancer, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

The disorder, alpha1-antitrypsin deficiency (á1ATD), is one of the most common genetic conditions affecting the U.S. population and especially those of European descent, according to background information in the article. Individuals with two copies of the associated genetic mutation often develop emphysema at an early age. However, á1ATD carriers—those with only one copy of the mutated gene—do not normally have severe diseases related to á1ATD and may not be aware of their status. However, they may be more vulnerable to cancer-causing tobacco smoke than non-carriers.

Ping Yang, M.D., Ph.D., and colleagues at the Mayo Clinic, Rochester, Minn., tested for á1ATD carrier status in 1,443 patients with lung cancer. In addition, 797 community members without lung cancer and 902 siblings of lung cancer patients were tested as controls. Information was gathered about all participants’ smoking history, demographic characteristics and family history of cancer.

A total of 13.4 percent of the lung cancer patients and 7.8 percent of unrelated controls were á1ATD carriers. When patients with lung cancer were compared to non-related controls, á1ATD carriers had a 70 percent higher risk of developing lung cancer than non-carriers. Comparing patients with lung cancer to their cancer-free siblings, á1ATD carriers had twice the risk of developing lung cancer. The researchers estimated that á1ATD carrier status may account for 11 percent to 12 percent of the patients with lung cancer enrolled in the study.

Among those who had never smoked, á1ATD carrier status was associated with a 2.2-fold higher risk of lung cancer, with a 2-fold increased risk among light smokers and a 2.3-fold increased risk among moderate to heavy smokers. “Patients with a family history of lung cancer or other cancers in their first-degree relatives had a similar á1ATD carrier rate to those without such a family history, all significantly higher than the controls,” the authors write. “This finding suggests that increased lung cancer risk among á1ATD carriers is independent of a family history of cancer.”

“In summary, our findings demonstrate a paradigm in lung cancer etiology research and risk assessment that incorporates clinical and genetic markers for lung damage into a gene-environment interaction,” they conclude. “This knowledge may prove to be useful in further understanding the pathologic mechanisms of lung cancer development and in refining lung cancer risk assessment.”

###

(Arch Intern Med. 2008;168[10]:1097-1103. Available pre-embargo to the media at http://www.jamamedia.org.)

Editor’s Note: This study was supported by grants from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail .

Contact: Traci Klein
507-284-5005
JAMA and Archives Journals

RELATED STORIES:
Hormone replacement tied to lung cancer risk   Survey finds significant racial differences in lung cancer beliefs   Benefits of surgery for lung cancer unclear   Dietary Phytoestrogens Reduce Risk of Lung Cancer   Brain Irradiation in Lung Cancer   Race Not Root of Disparity in Lung Cancer Between Whites and Blacks   Radiation ‘Highly Effective’ in Early Lung Cancer   TRUST study data confirms safety and efficacy of erlotinib for advanced lung cancer   More signs lung cancer screening could save lives   Study finds hospitals of last resort deliver lower quality of lung cancer care   Lung Cancer: Who is a Candidate for Surgery?   Passive Smoke in Workplace Increases Lung Cancer Risk   Value of CT screening for lung cancer unclear   Lung Cancer: Treatment of Non-Small Cell Lung Cancer in the Elderly   Gene Panel Predicts Lung Cancer Survival   New lung cancer drug shows dramatic results for shrinking tumors   African-Americans’ Attitudes About Lung Cancer May Hinder Prevention   Lung cancer patients may live longer with Alimta   Carotenoid supplements tied to lung cancer risk   Researchers Identify Tumor-Suppressor Gene for Lung Cancer   Cancer immunotherapy shows long-term promise in lung cancer   Tumor budding identified as predictor for unfavorable outcome in lung cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]